Top 10 Companies in the (S)-1-Bromo-2-methylbutane (CAS 534-00-9) Market (2026): Market Leaders Powering Global Synthesis

MARKET INSIGHTS

Global (S)-1-Bromo-2-methylbutane (CAS 534-00-9) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 29.7 million in 2026 to USD 46.2 million by 2034, exhibiting a CAGR of 5.7% during the forecast period.

(S)-1-Bromo-2-methylbutane (CAS 534-00-9) is a chiral organobromine compound with the molecular formula C5H11Br, widely recognized as an important building block in asymmetric synthesis and fine chemical manufacturing. The compound features a stereogenic center at the second carbon position, making the (S)-enantiomer particularly valuable in pharmaceutical synthesis, agrochemical development, and specialty chemical research where stereospecific reactions are essential.

The market is steadily expanding, driven by growing demand from the pharmaceutical and life sciences sectors, where enantiomerically pure intermediates are increasingly required for the synthesis of active pharmaceutical ingredients (APIs). Furthermore, rising investments in chiral chemistry and the broader expansion of contract research and manufacturing organizations (CROs and CMOs) globally are contributing to consistent demand growth. Key suppliers of high-purity chiral alkyl bromides, including Sigma-Aldrich (Merck KGaA), TCI Chemicals, and Alfa Aesar, continue to maintain significant market presence through diversified specialty chemical portfolios.

(S)-1-Bromo-2-methylbutane (CAS 534-00-9) Market – View in Detailed Research Report

Top 10 Companies in the (S)-1-Bromo-2-methylbutane (CAS 534-00-9) Market (2026)

---

1️⃣ Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany / Rahway, USA
Key Offering: Research‑grade (S)-1‑Bromo‑2‑methylbutane, custom synthesis, GMP‑grade intermediates

Sigma‑Aldrich remains the benchmark supplier for chiral reagents, offering unparalleled purity and a robust global distribution network. Their integrated quality system ensures consistent enantiomeric excess (≥99% ee) and traceability, which is essential for pharmaceutical development and regulatory submissions.

Sustainability & Growth Initiatives:

• Investment in green synthetic routes to reduce halogen waste
• Partnerships with academic institutions for chiral methodology development
• Expansion of on‑site GMP facilities to support CDMO partners

---

2️⃣ TCI Chemicals (Tokyo Chemical Industry Co., Ltd.)

Headquarters: Tokyo, Japan
Key Offering: High‑purity (S)-1‑Bromo‑2‑methylbutane, custom scale synthesis, analytical services

TCI’s reputation for precision chemistry is reinforced by its state‑of‑the‑art chiral resolution processes, providing consistent optical purity for both small‑scale research and large‑scale pharmaceutical production.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient production lines
• Development of bio‑based bromide precursors
• Strategic collaborations with leading CROs for rapid API development

---

3️⃣ Alfa Aesar (Thermo Fisher Scientific)

Headquarters: Haverhill, USA
Key Offering: Laboratory‑grade (S)-1‑Bromo‑2‑methylbutane, bulk supply, analytical support

Alfa Aesar’s extensive catalog and flexible minimum order quantities make it a go‑to supplier for academic labs and early‑stage biotech startups that require reliable chiral reagents at scale.

Sustainability & Growth Initiatives:

• Reduction of hazardous waste through closed‑loop recycling
• Investment in digital order management for streamlined procurement
• Partnerships with university research centers to pilot new chiral processes

---

4️⃣ Combi‑Blocks Inc.

Headquarters: Austin, USA
Key Offering: Custom chiral alkyl bromides, rapid scale‑up services, GMP‑ready intermediates

Combi‑Blocks specializes in bespoke synthesis, enabling clients to access unique chiral building blocks with tailored purity and scale, which is especially valuable for late‑stage drug development.

Sustainability & Growth Initiatives:

• Adoption of solvent‑free synthesis protocols
• Collaboration with CDMOs to streamline API production
• Expansion of a dedicated chiral synthesis R&D hub

---

5️⃣ Oakwood Chemical

Headquarters: Bismarck, USA
Key Offering: Research‑grade (S)-1‑Bromo‑2‑methylbutane, custom synthesis, analytical testing

Oakwood’s flexible manufacturing model supports rapid turnaround for small‑batch orders, making it a preferred partner for academic labs and small‑to‑mid‑scale industrial projects.

Sustainability & Growth Initiatives:

• Implementation of green chemistry guidelines in all synthesis routes
• Development of a cloud‑based order tracking system
• Strategic alliances with regional research institutes

---

6️⃣ Shanghai Aladdin Biochemical Technology Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High‑purity (S)-1‑Bromo‑2‑methylbutane, bulk supply, GMP certification

Aladdin’s large‑scale production capabilities and rigorous quality control make it a key supplier for the rapidly growing Asian pharmaceutical market.

Sustainability & Growth Initiatives:

• Integration of renewable energy sources in manufacturing facilities
• Investment in automated chiral resolution equipment
• Partnerships with Chinese pharmaceutical companies for joint development

---

7️⃣ Acmec Biochemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Research‑grade (S)-1‑Bromo‑2‑methylbutane, custom synthesis, analytical support

Acmec’s focus on high‑purity chiral reagents and flexible order sizes caters to both academic and industrial customers seeking reliable supply chains.

Sustainability & Growth Initiatives:

• Reduction of solvent usage through process optimization
• Development of a digital compliance portal for customers
• Collaboration with local universities for chiral chemistry training

---

8️⃣ Fluorochem Ltd.

Headquarters: London, United Kingdom
Key Offering: High‑purity (S)-1‑Bromo‑2‑methylbutane, custom synthesis, analytical services

Fluorochem’s niche focus on fluorinated and halogenated intermediates provides a unique value proposition for specialty chemical research and development.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop solvent recovery systems
• Investment in green synthesis research
• Partnerships with European CDMOs to expand market reach

---

9️⃣ Synthonix Inc.

Headquarters: Boston, USA
Key Offering: Research‑grade (S)-1‑Bromo‑2‑methylbutane, custom synthesis, analytical support

Synthonix’s expertise in chiral synthesis and flexible production volumes make it a valuable partner for biotech and pharmaceutical companies looking to scale up chiral intermediates.

Sustainability & Growth Initiatives:

• Adoption of green solvent alternatives
• Investment in digital supply chain transparency
• Collaborations with academic research groups for new chiral methodologies

---

10️⃣ Alfa Aesar

Headquarters: Haverhill, USA
Key Offering: Laboratory‑grade (S)-1‑Bromo‑2‑methylbutane, bulk supply, analytical testing

Alfa Aesar continues to support the academic and industrial research communities with its extensive catalog and flexible order options.

Sustainability & Growth Initiatives:

• Reduction of hazardous waste through process optimization
• Digital procurement platform for streamlined ordering
• Partnerships with universities to promote green chemistry education

---

Download FREE Sample Report: (S)-1-Bromo-2-methylbutane (CAS 534-00-9) Market – View in Detailed Research Report

Get Full Report: (S)-1-Bromo-2-methylbutane (CAS 534-00-9) Market – View in Detailed Research Report

Market Outlook

The (S)-1‑Bromo‑2‑methylbutane market is poised for robust growth, driven by the expanding pipeline of chiral pharmaceuticals and the increasing demand for enantiomerically pure intermediates in agrochemical and specialty chemical sectors. The shift towards single‑enantiomer drug approvals and the rise of contract development and manufacturing organizations (CDMOs) are key catalysts, creating a sustained demand curve. Geographic diversification, with Asia‑Pacific emerging as the fastest‑growing region, is expected to capture a significant share of the market’s expansion, supported by local manufacturing capabilities and strategic partnerships.

Future Trends

• Acceleration of green chemistry initiatives to reduce halogen waste and improve safety.
• Growth of chiral catalyst development, enabling more efficient and scalable synthesis routes.
• Expansion of agrochemical applications, with chiral pesticides and herbicides gaining regulatory attention.
• Integration of digital supply chain solutions for real‑time quality monitoring and regulatory compliance.
• Emergence of advanced materials science, such as chiral liquid crystals and optically active polymers, creating new downstream markets.